Grail, Inc. (GRAL) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.
the bull case· 3
14
disclosed supplier and customer ties in SEC filings
sec filingsedgar4
funds on file reporting a position in GRAL
n-portas of Jun 30 '26+9.55%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26the bear case· 4
5 of 23
largest reporting managers cut their stake in the latest quarter
13fJun 30 '2622
managers whose positions together make up four fifths of reported value
13fJun 30 '263 of 8
recent reports where the move came in under the options implied range
earnings historyimplied vs realized0.91%
of State Street SPDR S&P Biotech ETF's assets as largest fund weight on file
n-portJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 13 '26 report. Not a forecast, not advice.
Of the 6 companies Grail, Inc. moves with most closely, none share its SEC classification.
Measured against 499 trading days of our own closes. Co-movement, not cause.
SIC 8071, Services-Medical Laboratories, from each company's own filings. Largest first.
373 managers report a position worth $2.7B between them, and 22 of them hold 80% of it.
tall tick = annual report · 1 on record
GRAL (Grail, Inc.) has 8 disclosed suppliers and 6 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
Grail, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services-Medical Laboratories
High 77.74 at 12:00 pm ET, low 74.96 at 10:30 am ET.